Comparing Aerobic to Resistance Training in Recovery From Cancer
This study has been completed.
Sponsor:
TriService Nursing Research Program
Information provided by:
Brooke Army Medical Center
ClinicalTrials.gov Identifier:
NCT00237926
First received: October 11, 2005
Last updated: July 29, 2008
Last verified: July 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the health outcomes of a 12-week exercise program focused on aerobic training (using a treadmill) to a 12-week exercise program focused on resistance training (using Thera-Bands) in sedentary patients within 6 months of completing treatment for cancer.
| Condition | Intervention |
|---|---|
|
Neoplasms |
Behavioral: Exercise |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Comparing Aerobic to Resistance Training in Recovery From Cancer |
Resource links provided by NLM:
Further study details as provided by Brooke Army Medical Center:
Primary Outcome Measures:
- quality of life [ Time Frame: 12-weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- exercise tolerance [ Time Frame: 12-weeks ] [ Designated as safety issue: No ]
| Enrollment: | 58 |
| Study Start Date: | November 2005 |
| Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
aerobic exercise
|
Behavioral: Exercise
aerobic or resistance training
|
|
Experimental: 2
Resistance Training
|
Behavioral: Exercise
aerobic or resistance training
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- have a biopsy-proven cancer diagnosis
- be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician
- be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks)
- have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory)
- be at least 18 years old
- be able to read and speak English
- have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated
Exclusion Criteria:
- following an exercise regimen a minimum of 3 times per week for at least 20 minutes each session within the previous 6 weeks
- bone or joint destruction that could be aggravated with exercise
- severe cognitive impairment identified by either the patient's medical care provider or by the study team
- neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00237926
Locations
| United States, Texas | |
| Brooke Army Medical Center | |
| Fort Sam Houston, Texas, United States, 78234 | |
Sponsors and Collaborators
TriService Nursing Research Program
Investigators
| Principal Investigator: | Stacey Young-McCaughan, RN, PhD | Department of Defense |
More Information
No publications provided
| Responsible Party: | Stacey Young-McCaughan, The Geneva Foundation at Brooke Army Medical Center |
| ClinicalTrials.gov Identifier: | NCT00237926 History of Changes |
| Other Study ID Numbers: | N05-006 |
| Study First Received: | October 11, 2005 |
| Last Updated: | July 29, 2008 |
| Health Authority: | United States: Federal Government |
Keywords provided by Brooke Army Medical Center:
|
Sleep Fatigue Exercise tolerance Quality of life Health status |
Additional relevant MeSH terms:
|
Neoplasms |
ClinicalTrials.gov processed this record on June 18, 2013